H.R. 9064 proposes to amend the Internal Revenue Code to temporarily increase the capital gains exclusion for seniors who sell their primary residence within a designated qualifying year. This means that qualifying seniors could exclude a larger amount of profit from the sale of their home from capital gains taxes, potentially providing financial relief during a time of transition.
Supporters of H.R. 9064 argue that the bill will help seniors downsize or relocate without facing significant tax burdens, thereby promoting financial stability and mobility for older Americans. Media outlets highlight the potential for this legislation to assist seniors in retaining more of their home sale profits, which could be particularly beneficial in high-cost housing markets.
Critics of H.R. 9064 express concerns that the bill may disproportionately benefit wealthier seniors, potentially exacerbating economic inequalities. Some media reports suggest that increasing the capital gains exclusion could lead to a loss of tax revenue, which might impact funding for essential public services. Additionally, there are worries that the temporary nature of the increase might create confusion and uncertainty for seniors considering selling their homes.
While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, the lobbying activity in the policy area raises some concerns. Notably, Hart Health Strategies contributed $40,000, and the Brain Injury Association of America contributed $30,000. These contributions could suggest a potential influence on the bill's provisions, particularly if they relate to senior citizens' health or housing stability. However, the absence of direct industry overlaps indicates that the risk of a significant conflict is somewhat mitigated. Voters should be aware that while the financial contributions do not directly correlate with the bill, the presence of lobbying efforts in related areas could suggest underlying interests that may not be immediately apparent.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| ENVIRI | ENVIRI | $140,000 |
| HART HEALTH STRATEGIES | TIM YEHL, LLC | $40,000 |
| ALLIANCE FOR AUTOMOTIVE INNOVATION | TIM YEHL, LLC | $30,000 |
| BRAIN INJURY ASSOCIATION OF AMERICA (FKA BRAIN INJURY ASSOCIATION) | BRAIN INJURY ASSOCIATION OF AMERICA (FKA BRAIN INJURY ASSOCIATION) | $30,000 |
| FM LABS | EQV STRATEGIC | $15,000 |
| BIG SKY SCIENTIFIC | EQV STRATEGIC | $15,000 |
| CUBE RECOVERY COMPANY (DBA TEMPIQ) | PILLSBURY WINTHROP SHAW PITTMAN LLP | $10,000 |
| THESEUS TECHNOLOGY CORPORATION | PILLSBURY WINTHROP SHAW PITTMAN LLP | $10,000 |
| QUANTIFIND | PILLSBURY WINTHROP SHAW PITTMAN LLP | $10,000 |
| OBSIDIA SEMICONDUCTORS INC. | PILLSBURY WINTHROP SHAW PITTMAN LLP | $10,000 |
| WINGXPAND | PILLSBURY WINTHROP SHAW PITTMAN LLP | $10,000 |
| ANITOX | EQV STRATEGIC | $7,500 |
| PROJECT LEGACY | THE FRIEDLANDER GROUP | undisclosed |
| THE FRIEDLANDER GROUP | THE FRIEDLANDER GROUP | undisclosed |
| THE PROJECT HONG KONG TRUST | THE PROJECT HONG KONG TRUST | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Nicole Malliotakis, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
